Pitcairn’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-20,303
| Closed | -$1.93M | – | 338 |
|
|
2025
Q3 | $1.93M | Sell |
20,303
-15,648
| -44% | -$1.44M | 0.15% | 120 |
|
|
2025
Q2 | $3.13M | Sell |
35,951
-2,042
| -5% | -$173K | 0.21% | 86 |
|
|
2025
Q1 | $3.41M | Buy |
37,993
+8,636
| +29% | +$773K | 0.21% | 95 |
|
|
2024
Q4 | $2.35M | Buy |
29,357
+7,711
| +36% | +$668K | 0.14% | 135 |
|
|
2024
Q3 | $1.95M | Sell |
21,646
-2,298
| -10% | -$193K | 0.12% | 164 |
|
|
2024
Q2 | $1.88M | Buy |
23,944
+3,362
| +16% | +$276K | 0.12% | 171 |
|
|
2024
Q1 | $1.79M | Buy |
20,582
+2,208
| +12% | +$188K | 0.12% | 168 |
|
|
2023
Q4 | $1.51M | Buy |
18,374
+3,414
| +23% | +$260K | 0.11% | 171 |
|
|
2023
Q3 | $1.17M | Buy |
14,960
+1,874
| +14% | +$157K | 0.1% | 187 |
|
|
2023
Q2 | $1.15M | Sell |
13,086
-878
| -6% | -$75.6K | 0.1% | 191 |
|
|
2023
Q1 | $1.13M | Buy |
13,964
+954
| +7% | +$77.8K | 0.1% | 181 |
|
|
2022
Q4 | $1.01M | Sell |
13,010
-1,615
| -11% | -$131K | 0.1% | 185 |
|
|
2022
Q3 | $1.18M | Buy |
14,625
+858
| +6% | +$77.1K | 0.13% | 150 |
|
|
2022
Q2 | $1.24M | Sell |
13,767
-2,150
| -14% | -$218K | 0.13% | 142 |
|
|
2022
Q1 | $1.77M | Buy |
15,917
+2,851
| +22% | +$301K | 0.15% | 124 |
|
|
2021
Q4 | $1.35M | Sell |
13,066
-1,874
| -13% | -$217K | 0.09% | 164 |
|
|
2021
Q3 | $1.87M | Buy |
14,940
+95
| +0.6% | +$12.3K | 0.13% | 111 |
|
|
2021
Q2 | $1.84M | Buy |
14,845
+326
| +2% | +$40.9K | 0.12% | 117 |
|
|
2021
Q1 | $1.72M | Buy |
14,519
+3,367
| +30% | +$395K | 0.12% | 121 |
|
|
2020
Q4 | $1.31M | Buy |
11,152
+2,197
| +25% | +$242K | 0.1% | 138 |
|
|
2020
Q3 | $930K | Buy |
8,955
+6,069
| +210% | +$609K | 0.08% | 159 |
|
|
2020
Q2 | $265K | Sell |
2,886
-34
| -1% | -$3.26K | 0.03% | 387 |
|
|
2020
Q1 | $264K | Sell |
2,920
-779
| -21% | -$82.9K | 0.03% | 327 |
|
|
2019
Q4 | $420K | Buy |
3,699
+11
| +0.3% | +$1.21K | 0.04% | 291 |
|
|
2019
Q3 | $401K | Sell |
3,688
-735
| -17% | -$76.7K | 0.04% | 288 |
|
|
2019
Q2 | $431K | Buy |
4,423
+1,249
| +39% | +$114K | 0.04% | 279 |
|
|
2019
Q1 | $289K | Sell |
3,174
-695
| -18% | -$62.2K | 0.03% | 370 |
|
|
2018
Q4 | $352K | Buy |
3,869
+603
| +18% | +$56.3K | 0.04% | 259 |
|
|
2018
Q3 | $321K | Buy |
3,266
+68
| +2% | +$6.29K | 0.03% | 386 |
|
|
2018
Q2 | $274K | Sell |
3,198
-1,476
| -32% | -$123K | 0.03% | 437 |
|
|
2018
Q1 | $375K | Buy |
4,674
+893
| +24% | +$73.7K | 0.04% | 307 |
|
|
2017
Q4 | $305K | Buy |
+3,781
| New | +$303K | 0.03% | 385 |
|
|
2017
Q1 | – | Sell |
-6,720
| Closed | -$479K | – | 499 |
|
|
2016
Q4 | $479K | Sell |
6,720
-1,131
| -14% | -$88.9K | 0.06% | 259 |
|
|
2016
Q3 | $678K | Sell |
7,851
-1,524
| -16% | -$133K | 0.08% | 186 |
|
|
2016
Q2 | $814K | Sell |
9,375
-13,107
| -58% | -$1.06M | 0.1% | 143 |
|
|
2016
Q1 | $1.69M | Sell |
22,482
-1,973
| -8% | -$149K | 0.21% | 73 |
|
|
2015
Q4 | $1.88M | Buy |
24,455
+11,804
| +93% | +$889K | 0.21% | 68 |
|
|
2015
Q3 | $847K | Buy |
+12,651
| New | +$932K | 0.11% | 153 |
|
|
2015
Q1 | – | Sell |
-6,674
| Closed | -$482K | – | 498 |
|
|
2014
Q4 | $482K | Buy |
6,674
+563
| +9% | +$39.1K | 0.05% | 248 |
|
|
2014
Q3 | $378K | Sell |
6,111
-125
| -2% | -$7.95K | 0.04% | 321 |
|
|
2014
Q2 | $397K | Buy |
6,236
+110
| +2% | +$6.68K | 0.04% | 300 |
|
|
2014
Q1 | $377K | Sell |
6,126
-763
| -11% | -$44.4K | 0.04% | 311 |
|
|
2013
Q4 | $396K | Sell |
6,889
-50
| -0.7% | -$2.83K | 0.04% | 317 |
|
|
2013
Q3 | $370K | Sell |
6,939
-271
| -4% | -$14.6K | 0.05% | 312 |
|
|
2013
Q2 | $371K | Buy |
+7,210
| New | +$356K | 0.05% | 299 |
|
Other funds holding MDT
Pitcairn's MDT Position: Q4 2025 in Review
Pitcairn sold out of Medtronic (MDT) in Q4 2025, closing a stake of 20,303 shares — an estimated $1.93M sold.
Pitcairn first reported a position in MDT in Q2 2013 and held it in 45 quarters. The position peaked at $3.41M in Q1 2025. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.
- Pitcairn reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
- Pitcairn sold 20,303 Medtronic shares in Q4 2025, an estimated $1.93M.
- Pitcairn first reported a position in Medtronic in Q2 2013 and held it in 45 quarters.
- Pitcairn's Medtronic position peaked at $3.41M in Q1 2025.
- 2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.
Based on Pitcairn's 13F filing for Q4 2025.